Community-acquired pneumonia in adults

Slides:

Advertisements

Similar presentations

The cost of diabetes and diabetes care

Advertisements

Clinical Microbiology and Infection

Communication and Empathy in the Patient-Centered Care Model—Why Simulation- Based Training Is Not Optional Jeanette R. Bauchat, MD Clinical Simulation.

Methicillin resistance is not a predictor of severity in community-acquired Staphylococcus aureus necrotizing pneumonia—results of a prospective observational.

Contemporary Diagnosis and Management of Unstable Angina

Evaluation of Proteinuria

Jessica P. Hollenbach, PhD, Michelle M. Cloutier, MD

Clinical Microbiology and Infection

PREFACE Primary Care: Clinics in Office Practice

Men's Health Primary Care: Clinics in Office Practice

Value in Health Regional Issues

Narrow-spectrum ß-lactam monotherapy in hospital treatment of community-acquired pneumonia: a register-based cohort study S. Rhedin, I. Galanis, F. Granath,

Low platelet counts predict mortality in severe community acquired pneumonia in children under 5 years of age: A hospital based observational study Anubha.

Antibiotic Resistance in Nosocomial Respiratory Infections

Treatment of Alcohol Withdrawal in Hospitalized Patients

Obsessive Compulsive Disorder: A Clinical Update

Michele A. Hanson, M.D., Daniel A. Dumesic, M.D.

Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia—a propensity-adjusted analysis G. Choudhury,

Preface Primary Care: Clinics in Office Practice

Antibiotic Therapy and 48-Hour Mortality for Patients with Pneumonia

Localized hypertrichosis after infectious rash in adults

The laws of acute otitis media

Nasolaryngoscopy Primary Care: Clinics in Office Practice

Preface Primary Care: Clinics in Office Practice

Telithromycin 800 mg once daily for seven to ten days is an effective and well-tolerated treatment for community-acquired pneumonia C. Carbon, S. Moola,

Evaluation of the Clinical Usefulness of Critical Patient Severity Classification System and Glasgow Coma Scale for Neurological Patients in Intensive.

PREFACE Primary Care: Clinics in Office Practice

Preface Primary Care: Clinics in Office Practice

Switch to oral antibiotics in the treatment of infective endocarditis is not associated with increased risk of mortality in non–severely ill patients

PREFACE Primary Care: Clinics in Office Practice

G. Höffken Clinical Microbiology and Infection

Preface Primary Care: Clinics in Office Practice

Community-acquired pneumonia: the evolving challenge

Predicted effects on antibiotic use following the introduction of British or North American guidelines for community-acquired pneumonia in The Netherlands

Imaging for the Management of Community-Acquired Pneumonia

Continuing Care for Patients Choosing the Emergency Department as a Site for Primary Care: Feasibility, Benefits, and EMTALA Considerations David L.

Photodynamic Therapy for Early Stage Central Type of Lung Cancer

Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community R.E. Warren, G. Harvey, R. Carr, D. Ward,

Levofloxacin in the treatment of ventilator-associated pneumonia

J. Bodilsen, C. T. Brandt, A. Sharew, M. Dalager-Pedersen, T

Demetra Antimisiaris, PharmD, BCGP, FASCP

T.M. File Clinical Microbiology and Infection

A review of the current guidelines for allergic rhinitis and asthma

Communication and Empathy in the Patient-Centered Care Model—Why Simulation- Based Training Is Not Optional Jeanette R. Bauchat, MD Clinical Simulation.

Best Practices for Patients With Chronic Migraine

Identification of risk factors associated with nosocomial infection by rotavirus P4G2, in a neonatal unit of a tertiary-care hospital R. Herruzo, F.

Preface Primary Care: Clinics in Office Practice

Narrow-spectrum ß-lactam monotherapy in hospital treatment of community-acquired pneumonia: a register-based cohort study S. Rhedin, I. Galanis, F. Granath,

Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass.

Gastroenterology Primary Care: Clinics in Office Practice

Antibiotic De-Escalation

Clinical Microbiology and Infection

Preface Primary Care: Clinics in Office Practice

W. Eugene Sanders, Christine C. Sanders

Screening and Prevention in Primary Care

The atypical pneumonias: clinical diagnosis and importance

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Sleep Medicine Primary Care: Clinics in Office Practice

Preface Clinics in Laboratory Medicine

Preface Primary Care: Clinics in Office Practice

Adolescent Medicine Primary Care: Clinics in Office Practice

J.L. Balcázar Clinical Microbiology and Infection

Preface Primary Care: Clinics in Office Practice

Preoperative Smoking Cessation: The Role of the Primary Care Provider

Guy S. Reeder, M.D. Mayo Clinic Proceedings

Integrative Medicine and Primary Care

Urologic Commonalities and Challenges

Impact of antibiotic restrictions: the patient's perspective

Macrolide antibiotics and asthma treatment

Rajko Saletinger, Mario Poljak, Franc Strle

Presentation transcript:

Community-acquired pneumonia in adults Julio A Ramirez, MD Primary Care: Clinics in Office Practice Volume 30, Issue 1, Pages 155-171 (March 2003) DOI: 10.1016/S0095-4543(02)00076-3

Fig. 1 Classification of patients based on severity of pneumonia, site of care, and risk factors for resistant organisms. Primary Care: Clinics in Office Practice 2003 30, 155-171DOI: (10.1016/S0095-4543(02)00076-3)

Fig. 2 Likely organisms and empiric antibiotic therapy for patients in groups 1 and 2 (see text for specific antibiotics and details). Primary Care: Clinics in Office Practice 2003 30, 155-171DOI: (10.1016/S0095-4543(02)00076-3)

Fig. 3 Likely organisms and empiric antibiotic therapy for patients in group 3 (see text for specific antibiotics and details). Primary Care: Clinics in Office Practice 2003 30, 155-171DOI: (10.1016/S0095-4543(02)00076-3)

Fig. 4 Likely organisms and empiric antibiotic therapy for patients in groups 4 and 5 (see text for specific antibiotics and details). Primary Care: Clinics in Office Practice 2003 30, 155-171DOI: (10.1016/S0095-4543(02)00076-3)

Fig. 5 Time to switch therapy during the recovery phase of patients with CAP. Primary Care: Clinics in Office Practice 2003 30, 155-171DOI: (10.1016/S0095-4543(02)00076-3)

Fig. 6 Selection of oral antibiotics for switch therapy. Primary Care: Clinics in Office Practice 2003 30, 155-171DOI: (10.1016/S0095-4543(02)00076-3)